Abiomed, Inc.ABMDNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+13.2%
5Y CAGR+21.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+13.2%/yr
vs +34.2%/yr prior
5Y CAGR
+21.6%/yr
Recent deceleration
Acceleration
-21.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2022 | $188.16M | +16.2% |
| 2021 | $161.91M | +7.0% |
| 2020 | $151.31M | +16.8% |
| 2019 | $129.57M | +31.4% |
| 2018 | $98.58M | +39.6% |
| 2017 | $70.63M | +40.1% |
| 2016 | $50.42M | +26.2% |
| 2015 | $39.95M | +7.0% |
| 2014 | $37.32M | +18.1% |
| 2013 | $31.60M | - |